Name | 2-Chloro-N-(1-isopropyl-4-piperidinyl)-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinamine |
---|---|
Synonyms |
2-Chloro-N-(1-isopropyl-4-piperidinyl)-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinamine
4-Quinazolinamine, 2-chloro-6-methoxy-N-[1-(1-methylethyl)-4-piperidinyl]-7-[3-(1-pyrrolidinyl)propoxy]- |
Description | G9a-IN-1 (Compound 113) is a G9a protein inhibitor. G9A/EHMT2 is a nuclear histone lysine methyltransferase that catalyzes histone H3 lysine 9 dimethylation (H3K9me2), which is a reversible modification generally associated with transcriptional gene silencing. G9a-IN-1 can be used for the research of autoimmune disorders or cancer[1]. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 529.3±50.0 °C at 760 mmHg |
Molecular Formula | C24H36ClN5O2 |
Molecular Weight | 462.028 |
Flash Point | 273.9±30.1 °C |
Exact Mass | 461.255768 |
LogP | 4.89 |
Vapour Pressure | 0.0±1.4 mmHg at 25°C |
Index of Refraction | 1.600 |